Purpose

Sputum culture has been the best approach to detect harmful bacteria in the lungs of people with cystic fibrosis (CF). With the widespread use of new CF therapies (like Trikafta and Alyftrak), it is more difficult for people with CF to produce sputum even though they still have harmful bacteria in their lungs. The SEND-CF study is being done to see if there are other ways to detect harmful bacteria in the lungs.

Conditions

Eligibility

Eligible Ages
Over 16 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • ≥ 16 years of age on day of study visit - Documentation of CF Diagnosis - Able to expectorate sputum - Percent predicted FEV1 ≥ 30%

Exclusion Criteria

  • History of solid organ transplantation - History of active malignancy (or treatment for malignancy) in 12 months prior to the study visit - Pregnant

Study Design

Phase
Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Recruiting Locations

The Minnesota Cystic Fibrosis Center
Minneapolis, Minnesota 55455
Contact:
CF Trials Contact University of Minnesota, Participant Contact
cftrials@umn.edu

Washington University School of Medicine
St Louis, Missouri 63110
Contact:
Irma Bauer
irmabauer@wustl.edu

University of Pennsylvania
Philadelphia, Pennsylvania 19104
Contact:
Melissa Molter
melissa.molter@pennmedicine.upenn.edu

University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania 15224
Contact:
Adrienne DeRicco
adrienne.dericco2@upmc.edu

University of Texas Southwestern
Dallas, Texas 75390
Contact:
Ashley Keller
Ashley.Keller@UTSouthwestern.edu

Froedtert & Medical College of Wisconsin
Milwaukee, Wisconsin 53226
Contact:
Erin Hubertz
ehubertz@mcw.edu

More Details

Status
Recruiting
Sponsor
Chris Goss

Study Contact

Nikita Midamba
206-884-0599
Nikita.midamba@seattlechildrens.org

Detailed Description

People with cystic fibrosis (CF) often get lung infections that can make their breathing worse and make their lungs weaker over time. Sputum culture is usually analyzed to find these infections. Currently, many people with CF are using CFTR modulators. These medicines help, but they also make it harder for people to cough up sputum. Even though people with CF are making less sputum, lung infections are still a problem. New ways are needed to check for infections without using sputum. The SEND-CF study wants to gather health information and samples from people with CF in order to find new and better ways to spot harmful bacteria in the lungs. Participants, who typically are able to produce sputum who consent to participate will be asked to provide samples including sputum, saliva, serum, plasma, buffy coat, urine, and whole blood. Some participants will also provide breath samples for a sub-study.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.